DAVID MANION: Open Payments
NPI 1447297502 · WAYNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 103 payments from 15 companies in 2025. Trend: 2023 $918 · 2024 $1,223 · 2025 $1,666
Food & beverage: $1,613Education: $53
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $674 |
| Galderma Laboratories, L.P. | 12 | $210 |
| Janssen Biotech, Inc. | 13 | $200 |
| GENZYME CORPORATION | 8 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $147 |
| Almirall LLC | 2 | $72 |
| UCB, Inc. | 1 | $31 |
| LEO Pharma Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
Products named: RINVOQ, SKYRIZI, TREMFYA, NEMLUVIO, DUPIXENT, ILUMYA, Klisyri, Bimzelx.
Industry payments across PA — which companies pay providers there.
